LAM-话题@MedSci

#LAM#

157篇内容 | 4000人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2057695, encodeId=749d205e69579, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=NEJM：Risdiplam，脊髓性肌萎缩的第一个口服药, objectType=article, longId=208264, objectId=05b520826473, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05b520826473, replyNumber=0, likeNumber=67, createdTime=2021-11-14, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05b520826473, moduleTitle=NEJM：Risdiplam，脊髓性肌萎缩的第一个口服药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05b520826473)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057701, encodeId=b423205e701b6, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Inflammatory Bowel Diseases：克罗恩病患儿的身高发育障碍，男女有别！, objectType=article, longId=214059, objectId=1c9f21405989, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c9f21405989, replyNumber=0, likeNumber=77, createdTime=2022-03-17, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c9f21405989, moduleTitle=Inflammatory Bowel Diseases：克罗恩病患儿的身高发育障碍，男女有别！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c9f21405989)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057689, encodeId=1aff205e68912, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=J Inflamm Res：新研究鉴定了BX471对变应性鼻炎的治疗作用 , objectType=article, longId=200535, objectId=9d9f2005357c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9d9f2005357c, replyNumber=0, likeNumber=74, createdTime=2021-03-13, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9d9f2005357c, moduleTitle=J Inflamm Res：新研究鉴定了BX471对变应性鼻炎的治疗作用 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9d9f2005357c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057686, encodeId=e399205e686b6, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=RNAi巨头Alnylam公司再发力：出击非酒精性脂肪性肝炎（NASH）, objectType=article, longId=198731, objectId=37c9198e311c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37c9198e311c, replyNumber=0, likeNumber=84, createdTime=2021-02-15, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37c9198e311c, moduleTitle=RNAi巨头Alnylam公司再发力：出击非酒精性脂肪性肝炎（NASH）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37c9198e311c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057688, encodeId=6c4c205e688fc, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Inflammopharmacology：牙周非手术治疗后辅助使用褪黑素可改善CP患者的T2DM的炎症和牙周状态, objectType=article, longId=199335, objectId=3e6419933561, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3e6419933561, replyNumber=0, likeNumber=81, createdTime=2020-11-23, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3e6419933561, moduleTitle=Inflammopharmacology：牙周非手术治疗后辅助使用褪黑素可改善CP患者的T2DM的炎症和牙周状态, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3e6419933561)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057690, encodeId=0c88205e690ee, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Mediators Inflamm：每日膳食摄入量可降低马拉松比赛引起的炎症反应, objectType=article, longId=201521, objectId=c04220152195, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c04220152195, replyNumber=0, likeNumber=85, createdTime=2021-01-24, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c04220152195, moduleTitle=Mediators Inflamm：每日膳食摄入量可降低马拉松比赛引起的炎症反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c04220152195)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057696, encodeId=25e6205e69651, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=JNNP：TNF抑制剂治疗抗MOG相关脑炎伴癫痫（FLAMES）的单侧皮质FLAIR高信号病变, objectType=article, longId=209839, objectId=4a4820983914, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a4820983914, replyNumber=0, likeNumber=92, createdTime=2021-12-31, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a4820983914, moduleTitle=JNNP：TNF抑制剂治疗抗MOG相关脑炎伴癫痫（FLAMES）的单侧皮质FLAIR高信号病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4a4820983914)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057678, encodeId=2452205e678cf, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=FDA为Alnylam的RNAi疗法Lumasiran授予优先审查，用于治疗1型原发性高草酸尿症, objectType=article, longId=194823, objectId=beb619482390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=beb619482390, replyNumber=0, likeNumber=79, createdTime=2021-05-10, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=beb619482390, moduleTitle=FDA为Alnylam的RNAi疗法Lumasiran授予优先审查，用于治疗1型原发性高草酸尿症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=beb619482390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057676, encodeId=eb6f205e6769b, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Inflamm Bowel Dis：补充维生素D可能对IBD患者的上呼吸道感染有预防作用, objectType=article, longId=195047, objectId=024419504e44, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=024419504e44, replyNumber=0, likeNumber=54, createdTime=2021-01-26, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=024419504e44, moduleTitle=Inflamm Bowel Dis：补充维生素D可能对IBD患者的上呼吸道感染有预防作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=024419504e44)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057693, encodeId=174d205e693d7, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Mediators Inflamm：Th1-Th2失衡导致的趋化因子和细胞因子级联与HIV相关隐球菌脑膜炎中的颅内压升高有关, objectType=article, longId=204432, objectId=131620443251, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=131620443251, replyNumber=0, likeNumber=80, createdTime=2021-01-01, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=131620443251, moduleTitle=Mediators Inflamm：Th1-Th2失衡导致的趋化因子和细胞因子级联与HIV相关隐球菌脑膜炎中的颅内压升高有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=131620443251)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057692, encodeId=7389205e69257, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=p38α抑制剂Neflamapimod治疗路易体痴呆症的II期临床成功，患者认知显着提高, objectType=article, longId=201946, objectId=8c3820194642, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c3820194642, replyNumber=0, likeNumber=56, createdTime=2021-05-03, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c3820194642, moduleTitle=p38α抑制剂Neflamapimod治疗路易体痴呆症的II期临床成功，患者认知显着提高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c3820194642)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057672, encodeId=268e205e672c7, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Alynlam的RNAi药物lumasiran治疗原发性高草酸尿症，完成向欧盟和美国的申请, objectType=article, longId=191814, objectId=bcab1918142e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bcab1918142e, replyNumber=0, likeNumber=64, createdTime=2020-07-17, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bcab1918142e, moduleTitle=Alynlam的RNAi药物lumasiran治疗原发性高草酸尿症，完成向欧盟和美国的申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bcab1918142e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057677, encodeId=3935205e67743, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=罗氏的risdiplam在1型脊髓性肌萎缩症婴儿中展现出治疗潜力, objectType=article, longId=193313, objectId=4ca7193313fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ca7193313fb, replyNumber=0, likeNumber=63, createdTime=2021-02-04, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ca7193313fb, moduleTitle=罗氏的risdiplam在1型脊髓性肌萎缩症婴儿中展现出治疗潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ca7193313fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057679, encodeId=d022205e67925, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Inflammopharmacology：有效治疗炎症性疾病的药物研发出来了！, objectType=article, longId=195285, objectId=f5d419528555, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5d419528555, replyNumber=0, likeNumber=85, createdTime=2021-01-25, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5d419528555, moduleTitle=Inflammopharmacology：有效治疗炎症性疾病的药物研发出来了！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5d419528555)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057691, encodeId=0710205e69153, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Inflammation：孕期弓形虫感染会影响PD-1+Treg细胞功能从而导致不良的妊娠结局, objectType=article, longId=201606, objectId=40882016067f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40882016067f, replyNumber=0, likeNumber=75, createdTime=2021-03-09, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40882016067f, moduleTitle=Inflammation：孕期弓形虫感染会影响PD-1+Treg细胞功能从而导致不良的妊娠结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40882016067f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057680, encodeId=b05b205e68092, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=UCB以2.7亿美元收购Engage公司，及其手持口腔吸入式癫痫急救药物Staccato Alprazolam, objectType=article, longId=195460, objectId=3cd41954601e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3cd41954601e, replyNumber=0, likeNumber=70, createdTime=2021-03-26, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3cd41954601e, moduleTitle=UCB以2.7亿美元收购Engage公司，及其手持口腔吸入式癫痫急救药物Staccato Alprazolam, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cd41954601e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057682, encodeId=76a6205e68240, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=即刻起效，仅需超声引导！葛均波院士等报告自主研发ValveClamp治疗二尖瓣反流经验, objectType=article, longId=195552, objectId=b40f1955523a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b40f1955523a, replyNumber=0, likeNumber=66, createdTime=2020-11-28, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b40f1955523a, moduleTitle=即刻起效，仅需超声引导！葛均波院士等报告自主研发ValveClamp治疗二尖瓣反流经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b40f1955523a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057685, encodeId=47de205e6851b, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Immun Inflamm Dis：DENV特异性T细胞的功能表型与登革热的严重程度有关, objectType=article, longId=198103, objectId=007f198103cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=007f198103cb, replyNumber=0, likeNumber=100, createdTime=2020-10-25, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=007f198103cb, moduleTitle=Immun Inflamm Dis：DENV特异性T细胞的功能表型与登革热的严重程度有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=007f198103cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057687, encodeId=b929205e687e2, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=FDA批准Lampit（nifurtimox）用于治疗儿童恰加斯病, objectType=article, longId=199059, objectId=d47f1990592c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d47f1990592c, replyNumber=0, likeNumber=98, createdTime=2020-10-27, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d47f1990592c, moduleTitle=FDA批准Lampit（nifurtimox）用于治疗儿童恰加斯病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d47f1990592c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057681, encodeId=9001205e6815a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=ERA-EDTA 2020：RNAi疗法公司Alnylam再发力！Lumasiran治疗1型原发性高草酸尿症III期临床成功, objectType=article, longId=195493, objectId=6fc619549390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6fc619549390, replyNumber=0, likeNumber=75, createdTime=2021-02-21, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6fc619549390, moduleTitle=ERA-EDTA 2020：RNAi疗法公司Alnylam再发力！Lumasiran治疗1型原发性高草酸尿症III期临床成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6fc619549390)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

LAM

2020-05-29

lxg951 (审核中...)

前往app查看评论内容

#LAM#

NEJM：Risdiplam，脊髓性肌萎缩的第一个口服药

2021-11-14

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Inflammatory Bowel Diseases：克罗恩病患儿的身高发育障碍，男女有别！

2022-03-17

lxg951 (审核中...)

前往app查看评论内容

#LAM#

J Inflamm Res：新研究鉴定了BX471对变应性鼻炎的治疗作用

2021-03-13

lxg951 (审核中...)

前往app查看评论内容

#LAM#

RNAi巨头Alnylam公司再发力：出击非酒精性脂肪性肝炎（NASH）

2021-02-15

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Inflammopharmacology：牙周非手术治疗后辅助使用褪黑素可改善CP患者的T2DM的炎症和牙周状态

2020-11-23

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Mediators Inflamm：每日膳食摄入量可降低马拉松比赛引起的炎症反应

2021-01-24

lxg951 (审核中...)

前往app查看评论内容

#LAM#

JNNP：TNF抑制剂治疗抗MOG相关脑炎伴癫痫（FLAMES）的单侧皮质FLAIR高信号病变

2021-12-31

lxg951 (审核中...)

前往app查看评论内容

#LAM#

FDA为Alnylam的RNAi疗法Lumasiran授予优先审查，用于治疗1型原发性高草酸尿症

2021-05-10

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Inflamm Bowel Dis：补充维生素D可能对IBD患者的上呼吸道感染有预防作用

2021-01-26

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Mediators Inflamm：Th1-Th2失衡导致的趋化因子和细胞因子级联与HIV相关隐球菌脑膜炎中的颅内压升高有关

2021-01-01

lxg951 (审核中...)

前往app查看评论内容

#LAM#

p38α抑制剂Neflamapimod治疗路易体痴呆症的II期临床成功，患者认知显着提高

2021-05-03

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Alynlam的RNAi药物lumasiran治疗原发性高草酸尿症，完成向欧盟和美国的申请

2020-07-17

lxg951 (审核中...)

前往app查看评论内容

#LAM#

罗氏的risdiplam在1型脊髓性肌萎缩症婴儿中展现出治疗潜力

2021-02-04

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Inflammopharmacology：有效治疗炎症性疾病的药物研发出来了！

2021-01-25

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Inflammation：孕期弓形虫感染会影响PD-1+Treg细胞功能从而导致不良的妊娠结局

2021-03-09

lxg951 (审核中...)

前往app查看评论内容

#LAM#

UCB以2.7亿美元收购Engage公司，及其手持口腔吸入式癫痫急救药物Staccato Alprazolam

2021-03-26

lxg951 (审核中...)

前往app查看评论内容

#LAM#

即刻起效，仅需超声引导！葛均波院士等报告自主研发ValveClamp治疗二尖瓣反流经验

2020-11-28

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Immun Inflamm Dis：DENV特异性T细胞的功能表型与登革热的严重程度有关

2020-10-25

lxg951 (审核中...)

前往app查看评论内容

#LAM#

FDA批准Lampit（nifurtimox）用于治疗儿童恰加斯病

2020-10-27

lxg951 (审核中...)

前往app查看评论内容

#LAM#

ERA-EDTA 2020：RNAi疗法公司Alnylam再发力！Lumasiran治疗1型原发性高草酸尿症III期临床成功

2021-02-21

科室
- - 订阅+
  - 更多科室
工具
服务